Recombinant humanized monoclonal antibody to BCMA.
Applications
ELISA, FACS, Functional Assay, In Vivo
Reactivité
Human, Cynomolgus Macaque
Hôte
Humanized
Clonalité
Monoclonal
Isotype
IgG1
Chaînes légères
kappa
Conjuguer
Unconjugated
Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Masse moléculaire
This antibody has a predicted MW of 146.06 kDa.
Pureté
> 95% (by SDS-PAGE and SEC-HPLC).
Forme du produit
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Stockage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Synonymes
B cell maturation antigen, B cell maturation factor, B cell maturation protein, B-cell maturation protein, BCM, CD269, CD269 antigen, TNFRSF17, TNR17_HUMAN, Tumor necrosis factor receptor superfamily member 17
SDS-PAGE analysis of Belantamab Biosimilar - Anti-BCMA Antibody - Low endotoxin, Azide free (A323308) under reducing (R) conditions confirms that the purity of this antibody is greater than 95%.
SEC-HPLC analysis of Belantamab Biosimilar - Anti-BCMA Antibody - Low endotoxin, Azide free (A323308) confirms that the purity of this antibody is 100%.
U266 cells were stained with Belantamab Biosimilar - Anti-BCMA Antibody - Low endotoxin, Azide free (A323308) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC50 = 1.3980 µg/ml.
Produits alternatifs à Anti-BCMA Anticorps (A323308)